← back to search

Miranda Pring

University of Bristol · GB
Area of research
Otorhinolaryngology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Medicine, Head and neck cancer, Internal medicine, Cancer, Serology, and Immunology.
h-index
citations
451
works
26
NIH funding
primary concept
email

Recent publications

Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma
JAMA Otolaryngology–Head & Neck Surgery 2025cited by 4position: middledoi
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites
Nature Communications 2025cited by 3position: middledoi
Epstein-Barr Virus Antibody Response Patterns in Endemic and Nonendemic Cases of Nasopharyngeal Carcinoma
The Journal of Infectious Diseases 2025cited by 1position: middledoi
Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites
medRxiv 2024cited by 7position: middledoi
Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysis
JNCI Journal of the National Cancer Institute 2023cited by 33position: middledoi
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
JNCI Cancer Spectrum 2023cited by 18position: middledoi
A risk prediction model for head and neck cancers incorporating lifestyle factors, <scp>HPV</scp> serology and genetic markers
International Journal of Cancer 2023cited by 15position: middledoi
Diagnostic accuracy of <scp>HPV16</scp> early antigen serology for <scp>HPV</scp>‐driven oropharyngeal cancer is independent of age and sex
International Journal of Cancer 2023cited by 6position: middledoi
Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients
Cancers 2023cited by 4position: middledoi
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization
BMC Medicine 2022cited by 20position: middledoi
Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis
Cancer Epidemiology 2022cited by 14position: middledoi
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer
Nature Communications 2021cited by 41position: middledoi
Associations between markers of social functioning and depression and quality of life in survivors of head and neck cancer: Findings from the Head and Neck Cancer 5000 study
Psycho-Oncology 2021cited by 37position: middledoi
Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study
Head & Neck 2021cited by 16position: middledoi
Survival advantage in patients with human papillomavirus‐driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000
Cancer 2021cited by 15position: middledoi
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization
medRxiv 2021cited by 3position: middledoi
Quality of life, cognitive, physical and emotional function at diagnosis predicts head and neck cancer survival: analysis of cases from the Head and Neck 5000 study
European Archives of Oto-Rhino-Laryngology 2020cited by 33position: middledoi
<scp>Epstein‐Barr</scp> virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country
International Journal of Cancer 2020cited by 30position: middledoi
Disease trajectories, place and mode of death in people with head and neck cancer: Findings from the ‘Head and Neck 5000’ population-based prospective clinical cohort study
Palliative Medicine 2020cited by 27position: middledoi
HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer
Oral Oncology 2020cited by 27position: middledoi
Germline Determinants of Humoral Immune Response To HPV-16 Protect Against Oropharyngeal Cancer
Research Square 2020cited by 1position: middledoi
Squamous cell carcinoma of the nasal cavity: A descriptive analysis of cases from the head and neck 5000 study
Clinical Otolaryngology 2019cited by 12position: middledoi
Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000
Head & Neck 2019cited by 11position: middledoi
Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000
Head & Neck 2018cited by 56position: middledoi
DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival
Oral Oncology 2018cited by 17position: middledoi
Prevalence of human papillomavirus antibodies and survival in people with head and neck cancer: Results from head and neck 5000
Laryngo-Rhino-Otologie 2018cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tim Waterboer · German Cancer Research Center17 papers (2018–2025)Andy Ness · Palo Alto University12 papers (2018–2023)Michael Pawlita · Heidelberg University11 papers (2018–2021)Andrea Waylen · University of Bristol9 papers (2018–2021)Steve Thomas · University of Bristol7 papers (2018–2021)Nicole Brenner · German Cancer Research Center6 papers (2020–2023)Kate Ingarfield · Cardiff Metropolitan University6 papers (2018–2021)Katrina Hurley · Dalhousie University4 papers (2020–2025)Chris Penfold · University of Bristol4 papers (2018–2020)Julia Simon · German Cancer Research Center4 papers (2020–2025)Steven J. Thomas · University of Alabama at Birmingham4 papers (2019–2022)Zhiwei Liu · Tianjin University of Science and Technology3 papers (2020–2025)Tom Dudding · University of Manitoba3 papers (2021–2022)Rebecca C. Richmond · University of Bristol3 papers (2018–2022)Amy Davies · University of Bristol3 papers (2018–2019)Lea Schroeder · German Cancer Research Center3 papers (2020–2021)George Davey Smith · Laboratoire d’immunologie intégrative du cancer3 papers (2018–2022)Sam Leary · University of Bristol3 papers (2019–2020)Wan‐Lun Hsu · Fu Jen Catholic University2 papers (2023–2025)Mark Gormley · University of Bristol2 papers (2021–2022)